Rod S Taylor1, Massimo F Piepoli2, Neil Smart3, Andrew J S Coats4, Stephen Ellis5, Hayes Dalal6, Christopher M O'Connor7, Fiona C Warren8, David Whellan5, Oriana Ciani9. 1. Institute of Health Research, Exeter Medical School, University of Exeter, UK. Electronic address: r.taylor@exeter.ac.uk. 2. Heart Failure Unit, Guglielmo da Saliceto Hospital, Piacenza, Italy. 3. School of Science and Technology, University of New England, Armidale, NSW, Australia. 4. Monash University, Australia and University of Warwick, UK. 5. Duke Clinical Research Institute, NC, USA. 6. Research & Development, Knowledge Spa, Royal Cornwall Hospitals Trust, Truro & Primary Care Research Group, Exeter Medical School, UK. 7. Division of Cardiology and Clinical Pharmacology, Duke Heart Center, NC, USA. 8. Primary Care Research Group, Exeter Medical School, Exeter, UK. 9. Institute of Health Research, Exeter Medical School, University of Exeter, UK.
Abstract
BACKGROUND: Patients with chronic heart failure (HF) experience a marked reduction in their exercise capacity, health-related quality of life, and life expectancy. Despite substantive evidence supporting exercise training in HF, uncertainties remain in the interpretation and understanding of this evidence base. Clinicians and healthcare providers seek definitive estimates of impact on mortality, hospitalisation and health-related quality of life, and which HF patient subgroups are likely to most benefit. The original Exercise Training Meta-Analysis for Chronic Heart Failure (ExTraMATCH) individual participant data (IPD) meta-analysis conducted in 2004 will be updated by the current collaboration (ExTraMATCH II), to investigate the effects of exercise training in HF. METHODS: Randomised controlled trials have been identified from the updated 2014 Cochrane systematic review and the original ExTraMATCH IPD meta-analysis with exercise training of 3 weeks' duration or more compared with a non-exercise control and a minimum follow-up of 6 months. Particular outcomes of interest are mortality, hospitalisation and health-related quality of life plus key baseline patient demographic and clinical data. Original IPD will be requested from the authors of all eligible trials; we will check original data and compile a master dataset. IPD meta-analyses will be conducted using a one-step approach where the IPD from all studies are modelled simultaneously whilst accounting for the clustering of participants with studies. DISCUSSION: The information from ExTraMATCH II will help inform future national and international clinical and policy decision-making on the use of exercise-based interventions in HF and improve the quality, design and reporting of future trials in this field.
BACKGROUND: Patients with chronic heart failure (HF) experience a marked reduction in their exercise capacity, health-related quality of life, and life expectancy. Despite substantive evidence supporting exercise training in HF, uncertainties remain in the interpretation and understanding of this evidence base. Clinicians and healthcare providers seek definitive estimates of impact on mortality, hospitalisation and health-related quality of life, and which HF patient subgroups are likely to most benefit. The original Exercise Training Meta-Analysis for Chronic Heart Failure (ExTraMATCH) individual participant data (IPD) meta-analysis conducted in 2004 will be updated by the current collaboration (ExTraMATCH II), to investigate the effects of exercise training in HF. METHODS: Randomised controlled trials have been identified from the updated 2014 Cochrane systematic review and the original ExTraMATCH IPD meta-analysis with exercise training of 3 weeks' duration or more compared with a non-exercise control and a minimum follow-up of 6 months. Particular outcomes of interest are mortality, hospitalisation and health-related quality of life plus key baseline patient demographic and clinical data. Original IPD will be requested from the authors of all eligible trials; we will check original data and compile a master dataset. IPD meta-analyses will be conducted using a one-step approach where the IPD from all studies are modelled simultaneously whilst accounting for the clustering of participants with studies. DISCUSSION: The information from ExTraMATCH II will help inform future national and international clinical and policy decision-making on the use of exercise-based interventions in HF and improve the quality, design and reporting of future trials in this field.
Authors: Rod S Taylor; Sarah Walker; Neil A Smart; Massimo F Piepoli; Fiona C Warren; Oriana Ciani; David Whellan; Christopher O'Connor; Steven J Keteyian; Andrew Coats; Constantinos H Davos; Hasnain M Dalal; Kathleen Dracup; Lorraine S Evangelista; Kate Jolly; Jonathan Myers; Birgitta B Nilsson; Claudio Passino; Miles D Witham; Gloria Y Yeh Journal: J Am Coll Cardiol Date: 2019-04-02 Impact factor: 24.094
Authors: Rod S Taylor; Sarah Walker; Neil A Smart; Massimo F Piepoli; Fiona C Warren; Oriana Ciani; Christopher O'Connor; David Whellan; Steven J Keteyian; Andrew Coats; Constantinos H Davos; Hasnain M Dalal; Kathleen Dracup; Lorraine Evangelista; Kate Jolly; Jonathan Myers; Robert S McKelvie; Birgitta B Nilsson; Claudio Passino; Miles D Witham; Gloria Y Yeh; Ann-Dorthe O Zwisler Journal: Eur J Heart Fail Date: 2018-09-26 Impact factor: 15.534
Authors: Clara K Chow; Sheikh Mohammed Shariful Islam; Andrew Farmer; Kirsty Bobrow; Ralph Maddision; Robyn Whittaker; Leila Pfaeffli Dale; Andreas Lechner; Louis Niessen; Scott A Lear; Zubin J Eapen; Karla Santo; Sandrine Stepien; Julie Redfern; Anthony Rodgers Journal: BMJ Open Date: 2016-10-17 Impact factor: 2.692
Authors: Hafiz M Imran; Muhammad Baig; Sebhat Erqou; Tracey H Taveira; Nishant R Shah; Alan Morrison; Gaurav Choudhary; Wen-Chih Wu Journal: J Am Heart Assoc Date: 2019-08-17 Impact factor: 5.501
Authors: Viral A Sagar; Edward J Davies; Simon Briscoe; Andrew J S Coats; Hasnain M Dalal; Fiona Lough; Karen Rees; Sally Singh; Rod S Taylor Journal: Open Heart Date: 2015-01-28
Authors: Benjamin J R Buckley; Geert Kleinnibbelink; Gregory Y H Lip; Rod S Taylor; Dick H J Thijssen Journal: Int J Cardiol Heart Vasc Date: 2020-09-02